Imidazole 4-carboxamide compounds with adenosine deaminase...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/14 (2006.01) A61K 31/423 (2006.01) A61K 31/428 (2006.01) A61P 37/06 (2006.01) C07D 409/14 (2006.01) C07D 413/06 (2006.01) C07D 413/14 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2476164

Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I): wherein R1 is optionally substituted aryl or optionally substituted heteroaryl, R2 is lower alkyl; R3 is hydroxy or protected hydroxy; X is 0 or S; and - A - is lower alkylene, its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.

L'invention concerne des composés d'imidazole à activité d'inhibition de l'adénosine déaminase représentés par la formule (I), leur promédicament et leur sel. Dans ladite formule (I), R1 est éventuellement substitué par aryle ou hétéroaryle; R2 représente alkyle inférieur; R3 représente hydroxy ou hydroxy protégé; X est égal à O ou S; et - A - représente alkylène inférieur. Ces composés sont utilisés pour traiter et/ou prévenir des maladies pour lesquelles l'adénosine est efficace.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazole 4-carboxamide compounds with adenosine deaminase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazole 4-carboxamide compounds with adenosine deaminase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole 4-carboxamide compounds with adenosine deaminase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1823259

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.